The Muscle Stimulation Devices Market, estimated at USD 815.7 Mn in 2025, is expected to exhibit a CAGR of 3.8% and reach USD 1,059.0 Mn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
key market players are focused on adopting growth strategies such as acquisition and partnerships, which will drive the global muscle stimulation devices market. For instance, in March 2025, Hinge Health is Digital Musculoskeletal Clinic, is acquired the Enso Relief is a Medical Devices company headquarters in U.S., Its’s a clinically validated non-invasive, non-addictive technology used to help people with musculoskeletal (MSK) pain.
Global Muscle Stimulation Devices Market– Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2025 as "coronavirus disease 2025" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems with regard to the transportation of drugs from one place to another.
COVID-19 had a positive impact on the global muscle stimulation devices market. For instance, in May 2025, Liberate Medical's VentFree Respiratory Muscle Stimulator received United States Food and Drug Administration emergency approval. The device delivers stimulation in a non-invasive fashion, and the therapy can be initiated immediately at the start of ventilation and continued until patients are weaned off ventilation. This reduces the time of ventilation of the patients. This is attributed to increasing musculoskeletal disorders, technological advancement, emphasis on pain management therapies in sports medicine, and growing preference among physiotherapists for the disorders as muscle stimulators help in reducing muscle spasms, reducing discomfort and pain, restoring muscle tone, and rehabilitating parts of the body.
Global Muscle Stimulation Devices Market: Key Developments
Additionally, workshops and seminars related to Pain management across the world to promote muscle stimulator device are expected to boost market growth during the forecast period. For instance, in February 2025, MED-EL Medical Electronics is a Australian provider of hearing implant systems, Introduced STIWELL Neurorehabilitation & Electrotherapy. It’s electrotherapy device offers a comprehensive therapy concept for rehabilitation after neurological & orthopaedic diseases. In the workshop, Practical application of EMG-triggered multi-channel electrical stimulation including electrode attachment, case examples optionally with patient and theoretical background knowledge.